Study On Improving The Rule Of Law Of Drug Regulation In China ——From The Perspective Of Access To Medicines

As an essential commodity to ensure public life and health safety,medicine is closely related to the health rights and interests of every citizen.How to make every sick citizen can use qualified drugs,affordable use of qualified drugs,to ensure the maximum effectiveness of drugs to cure patients and improve the accessibility of drugs,is the top priority in China’s drug regulatory work.To make every patient use qualified drugs,it is necessary to implement drug quality and safety management,so that every patient can afford drug treatment,it is necessary to control drug price monopoly,so that drug prices return to a reasonable range.The scope of drug supervision involves the whole life cycle of drugs,and the research and development,production,sales and use of drugs are included in this chain.This article,however,is only to protect the public health rights and interests,improve the rule of law regulation target drug accessibility,around the quality and safety of drugs and drug price monopoly,the two level is also the most attention to the difficult problem of the public were analyzed,and look at the government and the other main pluralistic society of drug regulatory status and existing problems,to solve these problems put forward perfect path,In order to improve the accessibility and affordability of drugs,promote the stable development of the drug field,improve the effectiveness of supervision and protect the life and health safety of the public to provide legal protection.The first part of this paper defines the dual attributes of drug commodities and quasi-public goods and the subject of drug supervision from the perspectives of economics and law.The second part analyzes the connotation of drug accessibility,which includes the accessibility of drug quality and utility and the accessibility of drug price.Access to medicines is an important part of the right to health.In order to effectively protect the right to health of the public,it is necessary to strictly implement the supervision of drug quality,safety and price monopoly.In the third part,from the perspective of drug access,the status quo of drug quality safety and drug price monopoly supervision was analyzed in depth by combing relevant laws and regulations,national drug sampling and related cases.First,the counterfeit inferior drugs,which are extremely harmful in drug quality and safety,are defined by law,statistics of national drug sampling inspection,and management norms of Internet sales of prescription drugs and non-prescription drugs are analyzed.Second,it analyzes the institutional defects of price monopoly under the mechanism of drug price market,and classifies drug price monopoly,including three types: bulk drug market monopoly,administrative monopoly and patent drug monopoly.The fourth part is to analyze the problems and causes of drug quality and safety and price monopoly supervision.The fifth part,through the above subject crossing Angle analysis in the process of drug regulatory system problems and disadvantages of rules and regulations,combined with outside good regulatory experience,and improve the quality and safety of drug price monopoly regulation rules and optimize the beneficial ideas and Suggestions under the rule of law,safeguard the rights and interests of the public health implementation,improving drug accessibility and drug regulatory law regulation goal.